Author:
López-Iglesias Ana-Alicia,Herrero Ana B.,Chesi Marta,San-Segundo Laura,González-Méndez Lorena,Hernández-García Susana,Misiewicz-Krzeminska Irena,Quwaider Dalia,Martín-Sánchez Montserrat,Primo Daniel,Paíno Teresa,Bergsagel P. Leif,Mehrling Thomas,González-Díaz Marcos,San-Miguel Jesús F.,Mateos María-Victoria,Gutiérrez Norma C.,Garayoa Mercedes,Ocio Enrique M.
Funder
ISCIII-FIS
Spanish RTICC
Fundación Científica Asociación Española Contra el Cáncer
Regional Council of Castilla y León
Fundación Científica Asociación Española Contra el Cáncer (ES)
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Biology,Hematology
Reference47 articles.
1. Ocio E, Richardson P, Rajkumar S, Palumbo a, Mateos M, Orlowski R, et al. New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG). Leukemia. Nature Publishing Group; 2013;28:525–42
2. Majithia N, Vincent Rajkumar S, Lacy MQ, Buadi FK, Dispenzieri A, Gertz MA, et al. Outcomes of primary refractory multiple myeloma and the impact of novel therapies. Am J Hematol. 2015;90:981–5.
3. BERGSAGEL DE, SPRAGUE CC, AUSTIN C, GRIFFITH KM. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806). Cancer Chemother Rep. 1962;21:87–99.
4. Chauhan D, Ray A, Viktorsson K, Spira J, Paba-Prada C, Munshi N, et al. In vitro and in vivo antitumor activity of a novel alkylating agent, melphalan-flufenamide, against multiple myeloma cells. Clin Cancer Res Off J Am Assoc Cancer Res. 2013;19:3019–31.
5. Mateos M-V, Oriol A, Rosiñol L, de Arriba F, Puig N, Martín J, et al. Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial. Haematologica. 2015;100:1096–102.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献